http://orcid.org/0000-0003-0176-6756
Figures
Abstract
Introduction
Precancerous lesions of the cervix are changes in cervical cells that make them more likely to develop into cancer. Understanding the prevalence and determinants of the precancerous lesions of the cervix among women helps to take an action like vaccination programs, improving screening coverage, and close management and follow-up which could decrease the morbidity and mortality caused by cervical cancer.
Materials and methods
The international databases, PubMed/MEDLINE, Web of Science, EMBASE, CINAHL, Google Scholar, Science Direct and Cochrane Library and unpublished reports were systematically searched. Two authors independently extracted all necessary data using a standardized data extraction format. STATA 14 statistical software was employed to analyse the data. The Cochrane Q test statistics and I2 tests were used to assess the heterogeneity between the studies. A random-effect model was computed to estimate the pooled prevalence of precancerous lesions of the cervix in Ethiopia. Determinants of the precancerous lesion of cervix (early initiation of sexual intercourse, multiple sexual partners, and history of sexually transmitted infection) were analysed.
Results
Thirteen studies fulfilled the inclusion criteria and included in the meta-analysis. The I2 test result showed high heterogeneity (I2, 93.2%, p = <0.001). Using the random effect analysis, the pooled prevalence of precancerous lesions of the cervix among women in Ethiopia was 14.21% (95% CI (10.49, 17.94). After adjusting of publication bias using trim-and-fill method, the pooled prevalence was 9.43% (95% CI (5.23, 13.62). Women who had multiple sexual partners in their lifetime (OR:2.67 CI: 1.49,4.79) and had a history of sexually transmitted infections (OR:6.22 CI: 2.99,12.92) were more likely to have a precancerous lesion of the cervix.
Citation: Tsehay B, Afework M (2020) Precancerous lesions of the cervix and its determinants among Ethiopian women: Systematic review and meta-analysis. PLoS ONE 15(10): e0240353. https://doi.org/10.1371/journal.pone.0240353
Editor: Maria Lina Tornesello, Istituto Nazionale Tumori IRCCS Fondazione Pascale, ITALY
Received: January 28, 2020; Accepted: September 24, 2020; Published: October 28, 2020
Copyright: © 2020 Tsehay, Afework. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: All relevant data are within the paper and its Supporting Information files.
Funding: No funding was obtained for this study.
Competing interests: The authors have declared that there is no competing interest.
List of abbreviations: CIN, Cervical Intraepithelial Neoplasia; HPV, Human Papillomavirus; JBI, Joanna Briggs Institute; PRISMA, Preferred Reporting Items for Systematic Reviews and Meta-Analysis; SNNPE, Southern Nations, Nationalities and Peoples of Ethiopia; STI, Sexually Transmitted Infection; VIA, Visual Inspection of the cervix with Acetic acid; VILI, Visual Inspection with Lugol’s Iodine
Introduction
Precancerous lesions of the cervix are changes to the cervical cells in an area called the transformation zone. According to the World Health Organization (WHO), this change can exist at any of three stages: cervical intraepithelial neoplasia stage 1 (CIN1), stage 2(CIN2), or stage 3 (CIN3). These conditions are not yet cancer. But if they aren’t treated, CIN2 or CIN3 collectively referred to as cervical intraepithelial neoplasia stage 2 plus (CIN2+) can progress to cervical cancer [1, 2].
Cervical cancer is the 3rd most common cancer among women worldwide, with an estimated 569,847 new cases and 311,365 deaths in 2018 [3]. The burden of cervical cancer is high in Central and South America, East Africa, South and-South-East Asia, the Western Pacific, and mainly worse in sub- Saharan Africa [4]. In Ethiopia, Cervical cancer is the 2nd most common female cancer in women aged 15 to 44 years. About 6,294 new cervical cancer cases are diagnosed annually [5]. Histologically most cases are squamous cell carcinoma followed by adenocarcinoma [6, 7].
The aim of cervical cancer screening is to identify women at risk and to ensure appropriate follow-up for those who have a positive or an abnormal test result. World health organization recommends ‘screen-and-treat’ approach for screening and treatment of precancerous lesions for cervical cancer prevention. Treatment is provided soon or, ideally, immediately after a positive screening test. Screening tests include a human papillomavirus (HPV) test, visual inspection with acetic acid (VIA), and cytology (Pap test) [2].
About 70% of women in the United States and Europe are screened at least once, every five years. However, in developing countries, only 5% of women are screened in this same time period [8].
Early detection and management of precancerous lesions of cervix require policymakers and technical input. Challenges faced by countries are lack of awareness of people about cervical cancer, absence of a policy framework, inadequate infrastructure, insufficient data, and evidence [3, 9].
Understanding the prevalence and determinants of the precancerous lesions of the cervix among women helps to take actions like vaccination programs, improving screening coverage, and close management and follow-up which could decrease the morbidity and mortality caused by cervical cancer.
In Ethiopia, different studies were conducted to determine the prevalence and factors associated with precancerous lesions of the cervix. These studies reported that the prevalence of precancerous lesions among women ranges from 6.7% to 27.7% [10–21]. The common factors reported by the studies were early initiations of first sexual intercourse, multiple sexual partners, and a history of STI [11, 12, 14, 16, 17, 19–23].
The findings from these studies were highly variable and inconsistent. Therefore, the main aim of this systematic review and meta-analysis is to determine the pooled prevalence and determinants of precancerous lesions of the cervix among women in Ethiopia using available studies. The findings of this review will have an input to policymakers and program planners in the design of appropriate interventions to decrease cervical cancer in the country. In addition, the review may serve as a baseline for future research in related topics.
Materials and methods
Study design and setting
A systematic review and meta-analysis was conducted to estimate the pooled prevalence and determinants of precancerous lesions of the cervix among Ethiopian women.
Search strategies
This meta-analysis was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) [24] (S1 Table). A comprehensive search with no date limits and written in the English language was performed to access relevant articles in the following databases: PubMed/MEDLINE, Google Scholar, Web of Science, EMBASE, CINAHL, Science Direct, and Cochrane Library. In addition, observational studies were searched through the review of reference lists and journals like PLOS one, BMC. Unpublished papers were searched through university databases. Studies identified by our search strategy were retrieved and managed using Endnote X7 (Thomson Reuters, Philadelphia, PA, USA) software. This comprehensive search of the literature was conducted between the 1st of October to the 1st of November, 2019 (S1 File).
Eligibility criteria
Inclusion criteria.
Study area: Only studies conducted in Ethiopia.
Population: Studies involving women eligible for screening services.
Publication condition: Both published and unpublished articles were included.
Study design: All observational study designs (i.e., Cross-sectional and/ or case-control) reporting the prevalence of precancerous lesion of the cervix and/ or factor were eligible for this review.
Language: Only articles reported in the English language were considered.
Measurement of outcome variables
This study has two main outcomes. The first outcome was the pooled prevalence of the precancerous lesions of the cervix among women in Ethiopia, estimated as the total number of women with lesion divided by the total number of women taking part in the study multiplied by 100. The second outcome of this study was to identify the determinants of precancerous lesions of the cervix among Ethiopian women. For the second outcome, we assessed the association between precancerous lesions of the cervix and its determinants in the form of the log odds ratio. For major determinants, the odds ratio was calculated based on binary outcomes from the primary studies.
Quality assessment
Quality assessment was performed using the 22-items “Strengthening the Reporting of Observational Studies in Epidemiology” (STROBE) checklist that relates to the title, abstract, introduction, methods, results, and discussion sections of articles [25]. Studies that scored more than 75% (17 out of the 22 items) were considered to have good quality (S2 Table).
Data extraction and recording
The data from the selected articles were extracted using a standardized data extraction format, adapted from the Joanna Briggs Institute (JBI), independently by two authors (BT and MA). Any disagreements during the data extraction were resolved through discussion and consensus. For the first outcome (prevalence), the data extraction format included the author, publication year, region(s) of the country where the study was conducted, sample size, study population, and prevalence with 95% CI. For the second outcome (determinants), data were extracted in a format of two-by-two tables, and then the log odds ratio for early initiations of first sexual intercourse, multiple sexual partners, and history of an STI was calculated based on the findings of the original studies.
Data analysis
The extracted data were entered into an excel sheet and imported to STATA version 14 for analysis. Heterogeneity among reported prevalence was assessed by using the inverse variance (I2) with Cochran Q statistics of 25, 50 and 75% as low, moderate and severe heterogeneity respectively with a p-value less than 0.05 [26]. In this meta-analysis, I2 values were found to be high (> 75%). Since this value is a definitive indicator of significant-high heterogeneity, the random-effects meta-analysis model was used to estimate the pooled prevalence of precancerous lesions of the cervix. The funnel plot was also used to visualize the presence of heterogeneity graphically. Possible differences between the studies were explored by subgroup analyses. The finding was presented using a forest plot with respective odds ratios and 95% confidence intervals. Evidence of publication bias was assessed using both Egger’s, and Begg’s tests with a p-value of less than 0.05 as a cut-off point [27, 28]. For the second outcomes, pooled odds ratios with 95% CI for each factor were used to determine the association between precancerous lesions of the cervix and its factors (early initiations of first sexual intercourse, multiple sexual partners and history of STI).
Results
Selection of studies
We searched 212 articles through the electronic searches, of which we excluded 168 articles based on the title. From the remaining 44 articles, 30 duplicate articles were excluded. Finally, 14 full-text articles were accessed for eligibility criteria. Based on the pre-defined criteria and after critical appraisal (one article [29] was excluded) and 13 articles were included in the final analysis (Fig 1).
Characteristics of included studies
A total of thirteen articles met the inclusion criteria. All the included studies were published between 2013 and 2019. We included both cross-sectional and case-control studies using an estimated sample size range from 284 [17] up to 528 [20]. About 5,108 women aged from 18–85 years were included to estimate the pooled prevalence of precancerous lesions of the cervix and its associated factors among women in Ethiopia Table 1.
Pooled prevalence of precancerous lesion of the cervix (meta-analysis)
The minimum prevalence of precancerous lesions of the cervix was 6.7% as reported in a study conducted in Tigray region [14]. The highest, 27.7% was observed in a study conducted in SNNPE [20]. The I2 test result showed high heterogeneity (I2, 93.2%, p = <0.001). Using the random effect analysis, the pooled prevalence of the precancerous lesions of the cervix among women in Ethiopia was 14.21% (95% CI (10.49, 17.94)) (Fig 2). After adjusting of publication bias using trim-and-fill method, the pooled prevalence was 9.43% (95% CI (5.23, 13.62).
The diamond represents the pooled prevalence where us the outer edge of the diamond represents the 95% CI. The box with the back line represents the prevalence of each study with 95% CI.
Subgroup analysis by study area
Subgroup analyses by study area were conducted to assess the potential heterogeneity between studies. Of the 11 studies, the highest prevalence of the precancerous lesion of the cervix occurred in studies conducted in SNNPE region (19.83%, 95% CI 8.62% to31.04%, I2 = 97.0%), followed by studies conducted in Amhara region (12.98%, 95% CI 8.42% to 17.53%, I2 = 90.0%). We summarize subgroup analyses by regions in (Fig 3).
Publication bias
Evidence of publication bias was assessed using both Egger’s, and Begg’s tests with a p-value of less than 0.05 as a cut-off point and funnel plot. The funnel plot appeared asymmetrical and showed publication bias subjectively (Fig 4). The Egger weighted regression (P = 0.002) and Begg rank correlation test (p = 0.005) objectively revealed evidence of publication bias. To reduce this publication bias Trim and fill analysis was conducted and the result was depicted on (Fig 5).
Sensitivity analysis
The influence of a single study on the overall meta-analysis estimate was employed. Based on this the point estimate of its omitted analysis lies within the confidence interval of the combined analysis (Fig 6). This suggested that no single study unduly influenced the overall prevalence estimate of a precancerous lesion of the cervix among Ethiopian women.
Determinants of the precancerous lesions of the cervix among Ethiopian women
Early initiation of first sexual intercourse and the precancerous lesions of the cervix.
In this meta-analysis, we examined the association between early initiation of first sexual intercourse and precancerous lesions of the cervix depending on four studies [11, 12, 20, 23]. The result of the test statistics showed severe heterogeneity (I2 = 96.1% and p<0.0001). Therefore, a random effect meta-analysis model was employed to determine the association (Fig 7). Based on this, the occurrence of precancerous lesions of the cervix was not significantly associated with early initiation of first sexual intercourse.
The association of multiple sexual partners and the occurrence of precancerous lesions of the cervix.
A meta-analysis of six studies [10, 12, 16, 17, 20, 23] was conducted to determine the association between having multiple sexual partners and the occurrence of the precancerous lesions of the cervix. The result of the test statistics indicated the presence of severe heterogeneity (I2 = 83.6% and p<0.0001). Therefore, a random effect meta-analysis model was employed to determine the association (Fig 8). The results from these studies revealed that the occurrence of the precancerous lesions of the cervix was significantly associated with the presence of multiple sexual partners. Based on these women who had multiple sexual partners in their lifetime were 2.67 times more likely to have the precancerous lesions of the cervix than those who had not multiple sexual partners (OR:2.67 CI: 1.49,4.79).
The association of history of STI and the precancerous lesion of the cervix.
The association between history of STI and the precancerous lesion of the cervix among Ethiopian women was analysed based on five studies [10, 14, 16, 17, 19]. The result of the test statistics indicated the presence of severe heterogeneity (I2 = 83.4% and p<0.0001). Therefore, a random effect meta-analysis model was employed to determine the association (Fig 9). The results from these studies revealed that the occurrence of precancerous lesions of the cervix was significantly associated with a history of STI. Accordingly, women who had history of STI were 6.22 times more likely to have the precancerous lesions of the cervix than those with no history of STI (OR:6.22 CI: 2.99,12.92).
Discussion
This review was conducted to determine the pooled prevalence and determinants of the precancerous lesions of the cervix among Ethiopian women using published and unpublished studies. Understanding the prevalence and determinants of the precancerous lesions of the cervix among women is a base for the establishment of screening and vaccination programs. This indirectly could decrease the morbidity and mortality caused by cervical cancer.
The pooled meta-analysis of this review found that the prevalence of precancerous lesions of the cervix among Ethiopian women was 14.21% (95% CI (10.49, 17.94)). After adjusting of publication bias using trim-and-fill method, the pooled prevalence was 9.43% (95% CI (5.23, 13.62). This is lower than the previous studies conducted in Thailand (13.3%) [30], Uganda (13.6%) [31], Botswana (15.2%) [32], Sudan (16%) [33], Nigeria (16%) [34], Bangladesh (18%) [33], Kenya (26.7%) [35], Greece (49.5%) [36], Zambia (76%) [37]. It is also lower than the pooled prevalence of precancerous lesions of the cervix among HIV-positive women in sub-Saharan Africa 25.6% [38]. On the other hand, it is higher than the reports of Cameron (3.9%) [39], Rwanda (5.9%) [40], Uganda (7.8%) [41], and comparable with study in Tanzania (9.7%) [24], Madagascar (11.3) [41], Malawi (12.4%) [41], and Latin America (12%) [42].
There could be several reasons for the difference in the prevalence of the precancerous lesions of the cervix from one country to another. These may include the existence and consistency of screening programs and management options implemented in these countries; differences in the sexual practices of the women studied, and the differences in the study populations.
Subgroup analysis of studies based on region revealed that the highest prevalence of precancerous lesions of the cervix occurred in SNNPE region (19.83%), followed by studies conducted in the Amhara region (12.98%). Such regional difference may be due to differences in the study population, culture, religion and sociodemographic factors.
In this review, we have identified the pooled determinants of precancerous lesions of the cervix among Ethiopian women. The occurrence of precancerous lesions of the cervix was significantly associated with the presence of multiple sexual partners. Women who had multiple sexual partners in their lifetime were 2.67 times more likely to have the precancerous lesion of the cervix than those who had no multiple sexual partners. This is in line with studies done in Côte D’Ivoire [43], Swaziland [44], Kenya [45], united states [46], Italy [47], and Tanzania [48]. Women having multiple sexual partners may be exposed to factors predisposing to the precancerous lesions of the cervix such as HIV and STI.
Other determinant of precancerous lesions of the cervix in our review was a history of STI. The results from these studies revealed that the occurrence of the precancerous lesions of the cervix was significantly associated with a history of an STI. Accordingly, women who had a history of STI were 6.22 times more likely to have the precancerous lesions of the cervix than those with no history of an STI. This is supported by research done in Tanzania [48], Kenya [45, 49], Swaziland [44], Côte D'Ivoire [50], Zimbabwe [51], and India [52].
This may be due to the fact that infection with an STI in the presence of HPV increased the risk of CIN by causing inflammation which facilitates HPV persistence and hence cervical lesion and carcinogenesis [53]. HPV is mainly transmitted through sexual contact and most people are infected with HPV shortly after the onset of sexual activity. Cervical cancer is caused by sexually acquired infection with certain types of HPV. Two HPV types (16 and 18) cause 70% of cervical cancers and pre-cancerous cervical lesions [54].
Conclusion
The pooled prevalence of the precancerous lesions of the cervix among Ethiopian women was 14.21% and after adjusting publication bias by After adjusting of publication bias using trim-and-fill method, the pooled prevalence was 9.43%. It was associated with having multiple sexual partners and history of sexually transmitted infections.
Supporting information
S1 Table. PRISMA checklist: Recommended items addressed in our systematic review and meta-analysis.
https://doi.org/10.1371/journal.pone.0240353.s001
(PDF)
S2 Table. Quality assessment of included studies using the STROBE checklist.
https://doi.org/10.1371/journal.pone.0240353.s002
(PDF)
S1 File. Search strategy conducted between the 1st of October to the 1st of November, 2019.
https://doi.org/10.1371/journal.pone.0240353.s003
(PDF)
Acknowledgments
The authors of this work would like to forward great and deepest gratitude for Debre Markos and Addis Ababa University for creating a convenient environment and internet service.
References
- 1.
Canadian Cancer Society. Precancerous conditions of the cervix. 2019 October 1,2019]; Available from: https://www.cancer.ca/en/cancer-information/cancer-type/cervical/cervical-cancer/precancerous-conditions/?region=on.
- 2.
World Health Organization. Guidelines for screening and treatment of precancerous lesions for cervical cancer prevention WHO guidelines. 2013 October 10/2019]; Availablefrom: https://www.who.int/reproductivehealth/publications/cancers/screening_and_treatment_of_precancerous_lesions/en/.
- 3. Bray F., et al., Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians, 2018. 68(6): p. 394–424.
- 4. Jemal A., et al., Global cancer statistics. CA: a cancer journal for clinicians, 2011. 61(2): p. 69–90.
- 5.
HPV Information Centre. Human Papillomavirus and Related Diseases Report ETHIOPIA. 2019 October 12,2019]; Available from: https://www.hpvcentre.net/statistics/reports/ETH.pdf.
- 6. Arbyn M., et al., IARC Monographs programme on the evaluation of carcinogenic risks to humans. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, 2007. 90: p. 9–31.
- 7. Stanley M., HPV vaccines: are they the answer? British medical bulletin, 2008. 88(1): p. 59–74. pmid:18940889
- 8. Carr K.C. and Sellors J.W., Cervical cancer screening in low resource settings using visual inspection with acetic acid. Journal of midwifery & women's health, 2004. 49(4): p. 329–337.
- 9.
Federal Ministry of Health. Guideline for Cervical Cancer Prevention and Control in Ethiopia, Guideline for Cervical Cancer Prevention and Control in Ethiopia. 2013.
- 10. Gedefaw A., Astatkie A., and Tessema G.A., The prevalence of precancerous cervical cancer lesion among HIV-infected women in southern Ethiopia: a cross-sectional study. PloS one, 2013. 8(12): p. e84519. pmid:24376818
- 11. Deksissa Z.M., Tesfamichael F.A., and Ferede H.A., Prevalence and factors associated with VIA positive result among clients screened at Family Guidance Association of Ethiopia, south west area office, Jimma model clinic, Jimma, Ethiopia 2013: a cross-sectional study. BMC research notes, 2015. 8(1): p. 618.
- 12. Getinet M., et al., Prevalence and predictors of Pap smear cervical epithelial cell abnormality among HIV-positive and negative women attending gynecological examination in cervical cancer screening center at Debre Markos referral hospital, East Gojjam, Northwest Ethiopia. BMC clinical pathology, 2015. 15(1): p. 16.
- 13. Ameya G. and Yerakly F., Characteristics of cervical disease among symptomatic women with histopathological sample at Hawassa University referral hospital, Southern Ethiopia. BMC women's health, 2017. 17(1): p. 91. pmid:28962557
- 14. Misgina K.H., Belay H.S., and Abraha T.H., Prevalence of precancerous cervical lesion and associated factors among women in North Ethiopia. Journal of Public Health and Epidemiology, 2017. 9(3): p. 46–50.
- 15. Petros H. and Ayele A.A., Cervical Cancer Screening and Treatment Services in South West Shoa Zone of Oromia Region. Ethiopian Journal of Reproductive Health, 2018. 10(1): p. 7–7.
- 16. Teame H., et al., Factors associated with cervical precancerous lesions among women screened for cervical cancer in Addis Ababa, Ethiopia: A case control study. PloS one, 2018. 13(1): p. e0191506. pmid:29352278
- 17. Belayneh T., Mitiku H., and Weldegebreal F., Precancerous cervical lesion and associated factors among HIV-infected women on ART in Amhara Regional State, Ethiopia: A hospital-based cross-sectional study. International journal of health sciences, 2019. 13(3): p. 4. pmid:31123433
- 18. Derbie A., et al., Magnitude of cervical lesions and its associated factors using visual inspection with acetic acid (VIA) at a Referral Hospital in Ethiopia. Ethiopian Medical Journal, 2019. 57(2).
- 19. Kassa L.S., et al., Precancerous lesions of cervix among women infected with HIV in Referral Hospitals of Amhara Region, Northwest Ethiopia: a cross sectional study. African health sciences, 2019. 19(1): p. 1695–1704. pmid:31149000
- 20. Teka T., et al., Magnitude and Factors Associated with Precervical Cancer among Screened Women in Southern Ethiopia. Advances in Public Health, 2019. 2019.
- 21. Temesgen K., et al., Proportions of Pre-Cancerous Cervical Lesions and Its Associated Factors among Women Clients in the Age Group of 30-49yrs in Gynecology Ward of Dessie Referral Hospital and FGAE, North-East Ethiopia, 2016. Journal of Cancer and Tumor International, 2019: p. 1–15.
- 22. Gessese Z., et al., Determinant factors of Visual Inspection with Acetic Acid (VIA) positive lesions among HIV positive women in Mekelle Hospital, Northern Ethiopia: A case control study. Ethiopian medical journal, 2015. 53.
- 23.
Tesfalidet, Determinants of precancerous cervical lesion among women screened for cervical cancer in south Ethiopia: A case-control study. 2018.
- 24. Liberati A., et al., The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS medicine, 2009. 6(7): p. e1000100. pmid:19621070
- 25. Von Elm E., et al., The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Annals of internal medicine, 2007. 147(8): p. 573–577. pmid:17938396
- 26. Rücker G., et al., Undue reliance on I 2 in assessing heterogeneity may mislead. BMC medical research methodology, 2008. 8(1): p. 79.
- 27. Begg C.B. and Mazumdar M., Operating characteristics of a rank correlation test for publication bias. Biometrics, 1994: p. 1088–1101. pmid:7786990
- 28. Egger M., et al., Bias in meta-analysis detected by a simple, graphical test. Bmj, 1997. 315(7109): p. 629–634. pmid:9310563
- 29. Ansa M. and Mekonnen T., prevalence of via positive cervical lesions and determinant factors among women attending regular gynecology outpatient department (rgopd) at saint paul’s hospital millennium medical college (sphmmc). Ethiopian Journal of Reproductive Health, 2018. 10(2): p. 11–11.
- 30. Royal Thai Collegeof Obstetricians, Safety, acceptability, and feasibility of a single-visit approach to cervical-cancer prevention in rural Thailand: a demonstration project. The lancet, 2003. 361(9360): p. 814–820.
- 31.
Mugabe, K., Prevalence and factors associated with precancerous cervical lesions among HIV-positive women attending Mulago Hospital, Uganda. 2013.
- 32. Koutsky L.A., et al., A controlled trial of a human papillomavirus type 16 vaccine. New England Journal of Medicine, 2002. 347(21): p. 1645–1651. pmid:12444178
- 33. Bradford L.S., et al., Development of a cervical cancer screening program in a slum setting using visual inspection with acetic acid: analysis of feasibility and cost. Open Journal of Obstetrics and Gynecology, 2012. 2(02): p. 140.
- 34. Ogunbowale T. and Lawoyin T.O., Cervical cancer risk factors and predictors of cervical dysplasia among women in south‐west Nigeria. Australian Journal of Rural Health, 2008. 16(6): p. 338–342. pmid:19032205
- 35. Memiah P., et al., Prevalence and risk factors associated with precancerous cervical cancer lesions among HIV-infected women in resource-limited settings. AIDS research and treatment, 2012. 2012.
- 36. Modinou O., et al., Management of precancerous lesions of the uterine cervix according to demographic data. ISRN obstetrics and gynecology, 2010. 2011.
- 37. Parham G.P., et al., Prevalence and predictors of squamous intraepithelial lesions of the cervix in HIV-infected women in Lusaka, Zambia. Gynecologic oncology, 2006. 103(3): p. 1017–1022. pmid:16875716
- 38. Weldegebreal F. and Worku T., Precancerous Cervical Lesion Among HIV-Positive Women in Sub-Saharan Africa: A Systematic Review and Meta-Analysis. Cancer Control, 2019. 26(1): p. 1073274819845872. pmid:31043067
- 39. Tebeu P., et al., Prevalence and geographical distribution of precancerous lesions of the uterine cervix in Cameroon. J Cytol Histol, 2013. 4(183): p. 45–53.
- 40. Makuza J.D., et al., Prevalence and risk factors for cervical cancer and pre-cancerous lesions in Rwanda. Pan African Medical Journal, 2015. 22(1).
- 41.
World Health Organization International Agency for Research on Cancer, Prevention of cervical cancer through screening using visual inspection with acetic acid (VIA) and treatment with cryotherapy. A demonstration project in six African countries: Malawi, Madagascar, Nigeria, Uganda, the United Republic of Tanzania, and Zambia. 2012.
- 42. Sarian L., et al., Evaluation of visual inspection with acetic acid (VIA), Lugol's iodine (VILI), cervical cytology and HPV testing as cervical screening tools in Latin America: This report refers to partial results from the LAMS (Latin AMerican Screening) study. Journal of medical screening, 2005. 12(3): p. 142–149. pmid:16156945
- 43. Adjorlolo-Johnson G., et al., Assessing the relationship between HIV infection and cervical cancer in Cote d'Ivoire: a case-control study. BMC infectious diseases, 2010. 10(1): p. 242.
- 44. Jolly P.E., et al., Screening, prevalence, and risk factors for cervical lesions among HIV positive and HIV negative women in Swaziland. BMC public health, 2017. 17(1): p. 218. pmid:28222714
- 45. Temmerman M., et al., Risk factors for human papillomavirus and cervical precancerous lesions, and the role of concurrent HIV‐1 infection. International Journal of Gynecology & Obstetrics, 1999. 65(2): p. 171–181.
- 46. Shi R., et al., Factors associated with genital human papillomavirus infection among adult females in the United States, NHANES 2007–2010. BMC research notes, 2014. 7(1): p. 544.
- 47. Ursu R.G., et al., The need for cervical cancer control in HIV-positive and HIV-negative women from Romania by primary prevention and by early detection using clinically validated HPV/DNA tests. PloS one, 2015. 10(7): p. e0132271. pmid:26186361
- 48. Kafuruki L., et al., Prevalence and predictors of cervical intraepithelial neoplasia among HIV infected women at Bugando Medical Centre, Mwanza-Tanzania. Infectious agents and cancer, 2013. 8(1): p. 45. pmid:24228805
- 49. Huchko M.J., et al., Risk factors for cervical precancer detection among previously unscreened HIV‐infected women in Western Kenya. International journal of cancer, 2014. 134(3): p. 740–745. pmid:23900762
- 50. Ruche G.L., et al., Squamous intraepithelial lesions of the cervix, invasive cervical carcinoma, and immunosuppression induced by human immunodeficiency virus in Africa. Cancer: Interdisciplinary International Journal of the American Cancer Society, 1998. 82(12): p. 2401–2408.
- 51. Vere M., Risk Factors for Cervical Precancer Lesions among Women Attending Cervical Cancer Screening Clinics in Harare, 2013. 2013.
- 52. Gopalkrishna V., et al., Chlamydia trachomatis and human papillomavirus infection in Indian women with sexually transmitted diseases and cervical precancerous and cancerous lesions. Clinical microbiology and infection, 2000. 6(2): p. 88–93. pmid:11168078
- 53. Mbulaiteye S.M., et al., HIV and cancer in Africa: mutual collaboration between HIV and cancer programs may provide timely research and public health data. Infectious agents and cancer, 2011. 6(1): p. 16. pmid:22004990
- 54.
World Health Organization. Human papillomavirus (HPV) and cervical cancer. 2019 November 1,2019]; Available from: https://www.who.int/news-room/fact-sheets/detail/human-papillomavirus-(hpv)-and-cervical-cancer.